FDA Extends Manufacturers’ UDI Compliance Time Due To COVID-19
Executive Summary
Due to the ongoing coronavirus crisis, regulators have put pushed back deadlines for meeting UDI requirements. In some instances, they will no longer require direct-mark UDI information if it can be garnered from other data on the device.
You may also be interested in...
US FDA Waits Until December To Enforce Unique Device Identifier Database For Low-Risk Devices
Agency won’t require manufacturers to submit class I devices to the database for an extra 75 days, and doesn't plan to enforce GUDID regulations against consumer health products.
FDA Updates Guidance On Unique Device Identification Labeling For Class I Devices
The US FDA’s most recent guidance revises UDI requirements for class I and unclassified medical devices the agency issued in July. Class I devices categorized as consumer health products will be exempt from some submission requirements.
US FDA Tweaks Direct Marking Rules In UDI Enforcement Delay
FDA’s latest update to Unique Device Identification compliance deadlines says the agency won’t enforce direct marking UDI rules for some existing devices if the UDI can be determined in other ways.